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Abstract - The presented experiment was carried out to determine the effectiveness of the inducible nitric oxide synthase 
inhibitor - aminoguanidine in modulating the toxicity of aluminum chloride on the nitrite levels, malondialdehyde 
concentration, reduced glutathione content, as well as cytochrome c oxidase activity of Wistar rats. The animals were 
killed 3 h and 30 days after treatment and the hippocampus was removed. The biochemical results show that aluminum 
acts as a pro-oxidant, while aminoguanidine exerts an antioxidant action in aluminum chloride-treated animals. We 
have also applied immunohistochemical techniques to identify iNOS expression after the treatment. Our data suggest 
that aminoguanidine can be effective in the protection of toxicity induced by aluminum chloride. 
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INTRODUCTION 
Aluminum (Al) is a neurotoxic metal that may be 
involved in the progression of neurodegenerative 
changes (Dave et al., 2002). Although the mecha-
nism of action is not known, Al has been shown to 
alter calcium (Ca2+) flux and homeostasis, and fa-
cilitate the peroxidation of membrane lipids (Bo-
jarski et al., 2008). Lipid peroxidation is one of the 
consequences of free radical reactions which causes 
the dysfunction and damage of cell membranes. 
Also, Al has been implicated as an etiological factor 
in several neurodegenerative diseases and as a de-
stabilizer of cell membranes (Zatta et al., 2002). 
Brain Al entry from the blood may involve 
transferrin-receptor mediated endocytosis and a 
more rapid process of transporting small molecular 
weight Al species. There appears to be an Al efflux 
from the brain, probably as Al citrate. The inter-
action between transferrin and its receptor may 
function as a general metal ion regulatory system in 
the central nervous system (CNS) (Van Gelder et 
al., 1995).  
Aluminum has the ability to produce neuro-
toxicity by many mechanisms: it promotes the forma-
tion and accumulation of insoluble amyloid beta 
(Abeta) and hyperphosphorylated tau (Kawahara et 
al., 2001). Aluminum exposure may not be sufficient 
to cause an abnormal production of the principal 
component of senile plaques directly, but it does 
exacerbate the underlying events associated with brain 
aging and thus could contribute to the progression of 
neurodegeneration (Ferreira et al., 2008; Mousavi and 
Hellström-Lindahl, 2009). Both Al and Abeta can 
potentiate free radical formation by stabilizing iron in 
its more damaging ferrous (Fe2+) form which can 
promote the Fenton reaction. The velocity at which 
Fe2+ is spontaneously oxidized to Fe3+ was significantly 
slowed in the presence of Al salts (Yang et al., 1999).  
Also, long-term exposure to Al impaired the 
glutamate-nitric oxide (NO)-cyclic GMP (cGMP) 
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pathway, reducing glutamate-induced activation of 
NO synthase (NOS) and NO-induced activation of 
the cGMP generating enzyme, guanylate cyclase 
(Sheldon and Robinson, 2007). Enzymatically 
derived NO has been implicated in numerous phy-
siological and pathological processes in the brain 
(Law et al., 2001). Nitric oxide is an enzymatic 
product of the NO-synthesizing enzyme NOS, 
which is present in the brain in three different 
isoforms, two constitutive enzymes (i.e., neuronal, 
nNOS, and endothelial, eNOS) and one inducible 
enzyme (iNOS) (Stepanichev et al., 2008). The 
expression and activity of iNOS play a pivotal role 
in sustained and elevated NO release (Pannu and 
Singh, 2007). Most of the published data suggest 
that neurons can respond to proinflammatory sti-
muli and take part in brain inflammation (Heneka 
and Feinstein, 2000). Neuronal iNOS expression 
has been described in different experimental set-
tings, including the cytokine stimulation of neuro-
nal cell lines and primary neurons in vitro, as well 
as in animal models of stroke and neurodegenera-
tion (Heneka and Feinstein, 2000).  
Neurodegenerative processes are characterized 
by a progressive and selective loss of neurons. 
Apoptosis under mitochondrial control has been 
implicated in this neuronal death process, involving 
the release of cytochrome c into the cytoplasm and 
the initiation of the apoptosis cascade (Ghribi et al., 
2001). Mitochondria are both targets and sources of 
oxidative stress (Fiskum et al., 2004). 
The neurons are extremely sensitive to attacks 
by destructive free radicals. Intracerebral Al appli-
cation has been linked to mitochondrial anomalies 
affecting cytochrome c oxidase (COX), and these 
anomalies may contribute to the abnormal produc-
tion of free radicals (Christen, 2000). In normal 
cells, oxygen derivatives are neutralized or elimi-
nated owing to the presence of a natural defense 
mechanism that involves enzymatic antioxidants 
(glutathione peroxidase, superoxide dismutase, ca-
talase) and water or fat-soluble non-enzymatic anti-
oxidants (vitamins C and E, glutathione, selenium) 
(Stanczyk et al., 2005). L-gamma-Glutamyl-L-cys-
teinyl-glycine, or glutathione (GSH), an antioxidant 
thiol, has a specific signaling role in redox regu-
lation (Fratelli et al., 2005). 
Our previous results demonstrated the positive 
effects of NOS inhibitors on the the development of 
neurotoxicity (Jovanović et al., 2006; Stevanović et 
al., 2008, 2009, 2010). In view of the above, the 
present investigation was undertaken to examine 
whether the production of NO, lipid peroxidation, 
GSH content and COX activity after receiving 
intracerebral injections of aluminum chloride 
(AlCl3) can be modulated by pretreatment with 
aminoguanidine (AG), a specific iNOS inhibitor.  
MATERIALS AND METHODS 
Animals 
Male adult Wistar rats, weighing 500 ± 50 g, were used 
for the experiments. Groups of two or three rats per 
cage (Erath, FRG) were housed in an air-conditioned 
room at a temperature of 23 ± 2 ºC with 55 ± 10% 
humidity and with lights on 12 h/day (07.00-19.00 h). 
The animals were given a commercial rat diet and tap 
water ad libitum. The animals used for procedure 
were treated in strict accordance with the NIH Guide 
for Care and Use of Laboratory Animals (1985). 
Experimental procedure 
The animals were anesthetized by intraperitoneal 
injections of sodium pentobarbital (0.04 g/kg b.w.). 
The rats were divided into four basic groups 
(according to drug treatment) and each group con-
sisted of 10 animals. Using a stereotaxic instrument 
for small animals, chemicals were applied by a Ha-
milton Microsyringe. The first group of animals 
received 10 μl of 0.9 % saline solution and served as 
a control. A single dose of AlCl3 (Sigma, USA) (3.7 
x 10-4 g/kg b.w. in 0.01 ml of deionized water), was 
injected into the CA1 sector of the hippocampus 
(coordinates: 2.5 A; 4.2 L; 2.4 V) (Konig and 
Klippel, 1963). The third and fourth group were 
treated with aminoguanidine (AG) (Sigma Che-
mical Co. USA; 1x10-4 g dissolved in saline solu-
tion) +AlCl3 and AG+saline solution. Aminoguani-
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dine was applied immediately before the neuro-
toxin/saline solution. In all treated animals the 
injected intracerebral volume was 10 μl and it was 
always injected into the same left side.  
For biochemical analysis, the rats were 
decapitated 3 h and 30 days after treatment and the 
brains were immediately removed. The ipsi- and 
contralateral hippocampus from individual animals 
were quickly isolated and homogenized in an ice-
cold buffer containing 0.25 M sucrose, 0.1 mM 
EDTA, 50 mM K-Na phosphate buffer, pH 7.2. 
Homogenates were centrifuged twice at 1580 x g for 
15 min at 4 ºC. The supernatant obtained by this 
procedure was then frozen and stored at -70 ºC 
(Gurd et al., 1974). 
For immunohistochemical analysis, the animals 
were decapitated 3 h after the treatment. The brains 
were removed from the skull, fixed in 4% 
paraformaldehyde (TAAB Laboratory Equipment, 
Aldermaston, UK) for at least 24 h and 
cryoprotected in graded sucrose at 4ºC. The brains 
were frozen in methylbutane and stored at -70ºC 
until cryosectioning (CRIOCUT-E Reichert-Yung). 
Biochemical analyses 
The hippocampus from each frozen brain was 
dissected bilaterally and a crude mitochondrial frac-
tion was prepared from each region as previously 
described. 
After deproteinization, the production of NO 
was evaluated by measuring the nitrite and nitrate 
concentrations. Nitrites were assayed directly 
spectrophotometrically at 492 nm, using the 
colorimetric method of Griess (Griess reagent: 1.5% 
sulfanilamide in 1 M HCl plus 0.15% N-(1-
naphthyl)ethylenediamine dihydrochloride in 
distilled water). However, the nitrates were pre-
viously transformed into nitrites by cadmium 
reduction (Navaro-Gonzalvez et al., 1998). 
The lipid peroxidation index was measured as a 
quantity of the produced malondialdehyde (MDA). 
The thiobarbituric acid reagent (TBAR-15% tri-
chloroacetic acid (Merck, Darmstadt)+0.375% 
TBA+0.25% mol HCl) reacted with the MDA 
formed from polysaturated fatty acids in the 
process of peroxidation. The product of the 
reaction (MDA) was measured spectrophoto-
metrically at 533 nm (Villacara et al., 1989). 
The content of reduced glutathione (GSH) was 
determined using 5,5-dithiobis-2-nitrobenzoic acid 
(DTNB, 36.9 mg in 10 ml of methanol), which 
reacted with the aliphatic thiol compounds in a 
Tris-HCl buffer (0.4 mol, pH-8.9), thus forming a 
yellow-colored p-nitrophenol anion. The intensity 
of color was used for the spectrophotometric 
measurement of GSH concentration at 412 nm. 
Brain tissue was prepared in 10% sulfosalicylic acid 
for GSH-determination (Anderson, 1986). 
Cytochrome c oxidase activity (COX) was 
measured as the decrease of absorbance during the 
oxidation of ferrous cytochrome c to ferric 
cytochrome c. The kinetics were followed in 
potassium-phosphate buffer (0.05M, pH-7.1) for 3-
5 min at 550 nm. Samples were pretreated with 
deoxycholate (7.5%). Sodium dithionite (1mM 
Na2S2O4) was used for the reduction of cytochrome 
c. Reaction started with the addition of the prepared 
sample (0.05ml) to the reduced solution of 
cytochrome c (0.95ml) (Hess and Pope, 1960). 
The protein content in the rat brain homoge-
nates (hippocampus, ipsi- and contralateral) was 
measured by the method of Lowry using bovine 
serum albumin (Sigma) as standard (Lowry et al., 
1951). 
Chemicals were purchased from Sigma (St. 
Louis, MO, USA). All used chemicals were of ana-
lytical grade. All drug solutions were prepared on 
the day of experiment.  
Processing of brain tissue and 
immunohistochemistry 
Frozen, 8 μm-thick sections were deposited on 
poly-L lysine coated slides and allowed to air dry. 
DakoCytomation EnVision + System-HRP kit was 
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Table 1. Nitrite levels (nM nitrite/mg protein) in the rat 
ipsilateral and contralateral hippocampus, 3 h and 30 days after 
the treatment. Data are means ± S.D. of 10 animals.  
Group Time point 
Hippocampus 
ipsilateral 
Hippocampus 
contralateral 
3 hours 13.98 ± 3.1 14.64 ± 2.5 
Control 
30 days 10.57 ± 1.7 11.02 ± 1.9 
3 hours 24.94 ± 6.4* 27.31 ± 8.7* 
AlCl3 
30 days 12.18 ± 3.1 14.54 ± 5.0 
3 hours 22.62 ± 8.5* 23.55 ± 5.7* 
AG+AlCl3 
30 days 12.19 ± 4.2 12.37 ± 1.6 
3 hours 8.18 ± 1.6•,♦ 9.1 ± 1.7•,♦ 
AG 
30 days 7.91 ± 1.3•,♦ 6.85 ± 1.1*,•,♦ 
 
*Indicates a statistically significant difference between treated 
(AlCl3-, AG+AlCl3- and AG-treated) and control (sham-operated) 
animals (P<0.05). 
♦Indicates a statistically significant difference between 
AG+AlCl3-treated and AG-treated animals (P<0.05). 
used in a two step IHC staining technique. Cryostat 
sections were fixed in acetone and endogenous 
peroxidase activity was blocked by peroxidase block 
(0.03% hydrogen peroxide containing sodium 
azide) (DakoCytomation) for 15 min. Slides were 
incubated with appropriate dilutions of mAb (mou-
se monoclonal iNOS antibody 1:25 (Santa Cruz 
Biotechnology, Inc.) for 60 min. After this, the 
slides were incubated with the labeled polymer 
(DakoCytomation) conjugated to goat anti-mouse 
immunoglobulins in Tris-HCl buffer containing 
stabilizing protein and an anti-microbial agent with 
addition of 5% normal rat serum for 30 min. 
Staining was completed by a 5-10 min incubation 
with 3,3`-diaminobenzidine (DAB) + substrate-
chromogen (DakoCytomation) which resulted in a 
brown-colored precipitate at the antigen site. Fi-
nally, the slides were counterstained with hema-
toxylin and mounted with Kaiser gel (Merck). Con-
trol slides were incubated in the same way, using 
mouse isotype-matched irrelevant Ab (produced in 
the MMA, Belgrade). 
Data presentation and analysis 
Data are expressed as means ± S.D. Statistical signi-
ficance was determined as p<0.05 using either the Stu-
dent’s t-test or ANOVA followed by Tukey’s t-test. 
RESULTS 
Nitrite levels in the rat hippocampus 
The results presented in Table 1 show the nitrite 
levels (nM/mg proteins) in ipsilateral and contrala-
teral hippocampal homogenates. At the early tested 
time – 3 h, the AlCl3 injection resulted in an in-
crease of nitrite production in both the ipsi- and 
contralateral hippocampus compared to control 
group. Also, AG+AlCl3 application resulted in an 
increase of nitrite production bilaterally in the hip-
pocampus after 3 h, compared to the control group. 
However, after 3 h, the AG injection resulted in 
lower nitrite levels compared to the AlCl3- and 
AG+AlCl3-treated groups. At 30 days after AG ap-
plication the levels of nitrite production showed de-
creases in the contralateral hippocampus compared 
with the control. Also, after 30 days the AG injec-
tion resulted in lower nitrite levels in both the ipsi- 
and contralateral hippocampus, compared to the 
AlCl3- and AG+AlCl3-treated animals (Table 1).  
Malondialdehyde concentration in rat hippocampus 
The effect of an intrahippocampal drug injection of 
MDA concentration (nM MDA/h/mg protein) in 
the hippocampus is shown in Table 2. At the early 
tested time – 3 h, the AlCl3 injection resulted in an 
increase of MDA concentration bilaterally in the 
hippocampus, compared to the control group. 
AG+AlCl3 application resulted in a decrease of 
MDA concentration bilaterally in the same brain 
structure after 3 h, compared to the AlCl3-treated 
group. After 3 h, AG injection resulted in a lower 
MDA concentration, compared to the control, 
AlCl3- and AG+AlCl3-treated animals. At 30 days 
after AlCl3 application the MDA concentration sho-
wed increases in the contralateral hippocampus, 
compared with the control. Also, after 30 days the 
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Table 2. Lipid peroxidation (nM MDA/h/mg protein) in the 
rat ipsilateral and contralateral hippocampus, 3 h and 30 days 
after the treatment. Data are means ± S.D. of 10 animals.  
Group Time point 
Hippocampus 
ipsilateral 
Hippocampus 
contralateral 
3 hours 23.28 ± 6.0 24.53 ± 2.6 
Control 
30 days 19.09 ± 4.8 18.82 ± 3.8 
3 hours 45.21 ± 11.3* 52.76 ± 15.8* 
AlCl3 
30 days 23.17 ± 3.7 25.94 ± 7.0* 
3 hours 19.8 ± 4.1• 18.91 ± 3.3• 
AG+AlCl3 
30 days 22.47 ± 3.0 21.21 ± 3.9 
3 hours 14.1 ± 3.2*,•,♦ 13.98 ± 3.0*,•,♦ 
AG 
30 days 16.24 ± 2.6•,♦ 14.34 ± 1.5•,♦ 
 
*Indicates a statistically significant difference between treated 
(AlCl3-, AG+AlCl3- and AG-treated) and control (sham-operated) 
animals (P<0.05). 
♦Indicates a statistically significant difference between 
AG+AlCl3-treated and AG-treated animals (P<0.05). 
Table 3. Reduced glutathione concentration (nM GSH/mg 
protein) in the rat ipsilateral and contralateral hippocampus, 3 
h and 30 days after the treatment. Data are means ± S.D. of 10 
animals.  
Group Time point 
Hippocampus 
ipsilateral 
Hippocampus 
contralateral 
3 hours 31.91 ± 10.7 34.27 ± 11.6 
Control 
30 days 25.15 ± 5.2 24.64 ± 9.2 
3 hours 155.57 ± 42.8* 164.16 ± 52.3* 
AlCl3 
30 days 30.57 ± 9.9* 32.97 ± 10.5 
3 hours 34.45 ± 7.5• 37.07 ± 10.3• 
AG+AlCl3 
30 days 3.19 ± 1.4*,• 3.33 ± 0.7*,• 
3 hours 22.05 ± 6.2*,•,♦ 20.18 ± 4.4•,♦ 
AG 
30 days 3.29 ± 1.1*,• 3.04 ± 1.1*,• 
 
*Indicates a statistically significant difference between treated 
(AlCl3-, AG+AlCl3- and AG-treated) and control (sham-operated) 
animals (P<0.05). 
•Indicates a statistically significant difference between treated 
(AG+AlCl3- and AG-treated) and AlCl3-treated animals (P<0.05). 
♦Indicates a statistically significant difference between AG+AlCl3-
treated and AG-treated animals (P<0.05). AG injection resulted in a lower MDA concentra-
tion in both the ipsi- and contralateral hippocam-
pus, compared to the AlCl3- and AG+AlCl3-treated 
animals (Table 2). 
Reduced glutathione content in rat hippocampus 
The results presented in Table 3 show the GSH 
content (nM GSH/mg protein) in the ipsilateral and 
contralateral hippocampal homogenates. AlCl3 
injection resulted in higher levels of GSH concen-
tration after 3 h bilaterally in the hippocampus, 
compared to the control group. After 3 h, 
AG+AlCl3 application resulted in lower GSH con-
tent in both the ipsi- and contralateral hippo-
campus, compared to the AlCl3-treated group. At 
the same tested time, AG application resulted in a 
lower GSH content in the ipsilateral hippocampus, 
compared to the control, as well as in both the ipsi- 
and contralateral hippocampus, lower values were 
measured compared to the AlCl3- and AG+AlCl3-
treated animals. At 30 days after AlCl3 application 
the GSH content was increased in the ipsilateral 
hippocampus, compared to the control. Intrahippo-
campal AG+AlCl3 injections resulted in generally 
lower contents of GSH compared to the control and 
AlCl3-treated animals. Also, after 30 days the AG 
injection resulted in lower GSH concentration, in 
both ipsi- and contralateral hippocampus, compa-
red to the control and the AlCl3-treated animals 
(Table 3). 
Activity of cytochrome c oxidase in rat hippocampus 
The activity of COX (mg cyt. c/mg protein) 
obtained for the ipsi- and contralateral hippocam-
pus were similar. The COX activity was signifi-
cantly lower bilaterally in the hippocampus after 
AlCl3 application compared to the saline-injected 
animals at all tested times (3 h, 30 days) (Table 4). 
Intrahippocampal AG+AlCl3 injection resulted in 
generally lower levels of COX activity compared to 
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Table 4. Cytochrome c oxidase activity (mg cyt.C/mg protein) 
in the rat ipsilateral and contralateral hippocampus, 3 h and 30 
days after the treatment. Data are means ± S.D. of 10 animals.  
Group Time point 
Hippocampus 
ipsilateral 
Hippocampus 
contralateral 
3 hours 0.24 ± 0.07 0.22 ± 0.07 
Control 
30 days 0.35 ± 0.1 0.31 ± 0.08 
3 hours 0.17 ± 0.05* 0.15 ± 0.04* 
AlCl3 
30 days 0.10 ± 0.03* 0.11 ± 0.03* 
3 hours 0.19 ± 0.06*,• 0.18 ± 0.05*,• 
AG+AlCl3 
30 days 0.22 ± 0.07*,• 0.20 ± 0.06*,• 
3 hours 0.22 ± 0.07*,• 0.19 ± 0.06*,• 
AG 
30 days 0.30 ± 0.08*,• 0.25 ± 0.08*,• 
 
*Indicates a statistically significant difference between treated 
(AlCl3-, AG+AlCl3- and AG-treated) and control (sham-operated) 
animals (P<0.05). 
•Indicates a statistically significant difference between treated 
(AG+AlCl3- and AG-treated) and AlCl3-treated animals (P<0.05). 
the control, while higher COX activity was 
measured at both tested times, compared to AlCl3-
treated animals. At both times a single AG injection 
resulted in lower COX activity bilaterally in hippo-
campus, compared to the controls, while higher 
COX activity were measured at the all tested times 
compared to the AlCl3-treated animals (Table 4). 
There was no statistically significant difference 
between the COX activity obtained from each he-
misphere after the treatment, although the injection 
site was in the ipsilateral hippocampus. 
iNOS 
Inducible NOS labeling was present in the control 
animals 3 h (Fig. 1A) after saline solution appli-
cation and enhanced in the AlCl3-treated animals 3 
h (Fig. 1B) after injection. Photomicrographs of a 
hippocampus immunostained for iNOS after a 
delay of 3 h following AG+AlCl3 is presented in Fig. 
1C, and after injection of AG in Fig. 1D. 
DISCUSSION 
The application of AlCl3 to the CA1 sector of the 
hippocampus resulted in the reduced activity of 
COX with a significant bilateral increase in the NO 
production, MDA concentration and GSH content 
in the hippocampus. This suggests that the inhi-
bition of NOS by AG protects the cells in this 
region from AlCl3-induced damage and may there-
fore limit the retrograde and anterograde spread of 
neurotoxicity. 
Nitric oxide can react with superoxide to form 
the very harmful peroxynitrite (ONOO-), a process 
referred to as oxidative stress, which is likely to play 
a role in neurodegenerative changes. Peroxynitrite 
causes considerable damage that exacerbates the 
damage caused by the hyperactive microglia. Under 
conditions of neurodegeneration, excessive activa-
tion of microglia can contribute to the neurodege-
nerative process by releasing potentially cytotoxic 
substances, including the cytotoxic free radical NO 
(Schubert et al., 2001). 
In our study, AlCl3 injection resulted in an 
increased nitrite production after 3 h, and in un-
changed nitrite concentration after 30 days, bila-
terally in hippocampus, compared to the controls 
(Table 1). It has been previously known (Tohgi et 
al., 1998) that the production and oxidation of NO 
in the brain increased in early stages of the disease 
while it was decreasing with elevating loss of 
neurons.  
Under the conditions of this experiment, 
AG+AlCl3 application produced a rapid (within 3 
h) increase in the nitrite levels in the hippocampus 
compared to the control animals (Table 1). Reactive 
glial cell properties could contribute to the patho-
mechanisms underlying Al intoxication by favoring 
oxidative neuronal damage and Abeta toxicity. A 
critical step is apparently reached when patholo-
gical glial activation is no longer restricted to mic-
roglia and includes astrocytes, which may lose their 
physiological negative feed-back control on 
microglial NO production and even contribute to 
neurotoxic ONOO- formation. 
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Fig. 1A-D. Immunohistochemical detection of iNOS expression
within the hippocampus at 3 h after injection of saline solution
(A), AlCl3 (B), AG+AlCl3 (C), as well as AG (D). The iNOS stain
was observed in both saline solution-(A) and AlCl3-injected 
animals (B). iNOS staining was not detected in the hippocampus
of AG+AlCl3-(C) and AG-injected rats (D). Magnification x 400.
 Literature results imply that the inhibition of 
iNOS protects cells from the toxicity caused by the 
secretory products of microglia and monocytes 
(Combs et al., 2001). In our experiment, at various 
times following the injection of AG the nitrite pro-
duction in the hippocampus decreased immediately 
(3 h), compared to the AG+AlCl3-treated animals, 
and continued to decrease gradually throughout the 
experiment (30 days) (Table 1).   
We have shown that 30 days after injection, the 
application of AG produced a decrease in nitrite 
production in the contralateral hippocampus com-
pared to the control (Table 1). The results of Gor-
lach et al. suggest that the tissue nitrate/nitrite con-
centration was significantly attenuated by treatment 
with AG not only in the ipsilateral but also in the 
contralateral hemisphere (Gorlach et al., 2000). 
Aminoguanidine inhibits not only iNOS but also 
other enzymes, such as nNOS and advanced glyca-
tion end-product synthase. Administration of the 
selective iNOS inhibitor AG prevents NO-accumu-
lation in the cortex and the impairment of gluta-
mate uptake in synaptosomes. A sustained overpro-
duction of NO via iNOS expression may be respon-
sible, at least in part, for some of the neurodegene-
rative changes caused by stress and support a pos-
sible neuroprotective role for specific iNOS inhi-
bitors in this situation (Olivenza et al., 2000). 
There are several lines of evidence that show a 
key role of reactive oxygen species (ROS) in both 
intracellular signaling and intracellular communi-
cation, processes involved in maintaining homeo-
stasis. On the other hand, when excessively produ-
ced in vivo, ROS are deleterious to the integral com-
ponents of the cell and cause their dysfunctions. 
Some experimental data indicate that ROS-media-
ted lipid peroxidation, protein oxidation and oxida-
tive alterations to nucleic acids are crucial events in 
the unfavorable actions of ROS (Juranek and Bezek, 
2005). Lipid peroxidation is a measure of tissue 
destruction. 
In our study, AlCl3 injection resulted in an 
increased MDA concentration after 3 h bilaterally, 
as well as after 30 days contralaterally in the hippo-
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campus compared to the controls (Table 2). Alumi-
num may facilitate increases in intracellular Ca2+ 
and ROS, and potentially contribute to the neuroto-
xicity induced by other neurotoxicants (Mundy et 
al., 1997). 
The AG+AlCl3 treatment which caused a signifi-
cant decrease in MDA concentration, especially at 3 h, 
compared to AlCl3-treated animals (Table 2), suggests 
activation of the antioxidative system, resulting in an 
aggressive oxidative mechanism blockade initiated by 
the neurotoxin application.  
The present data indicate that the inhibition of 
iNOS by AG can effectively decrease the MDA con-
centration bilaterally in the hippocampus in all tes-
ted times (3 h, 30 days) after the treatment com-
pared to AlCl3-treated animals (Table 2), pointing 
to the balance of oxidative mechanisms.  
It is conspicuous that there is a strong associa-
tion between free radical accumulation and the 
evolution of inflammatory-related responses (Had-
dad and Harb, 2005). The reduced form of gluta-
thione represents the main endogenous antioxi-
dative compound responsible for control of the re-
dox state in the cell, as well as extracellular space.  
In our study, AlCl3 injection resulted in an in-
creased GSH content after 3 h bilaterally in the 
hippocampus, compared to the controls (Table 3). 
It has been previously shown (Li et al., 1998) that 
Al3+ alters the phosphorylation of tau and causes its 
aggregations. Phosphorylation sensitizes tau to Al3+ 
and phosphorylated tau transforms irreversibly into 
a phosphatase and protease resistant aggregate in 
the presence of this metal ion. 
Decreased GSH content along with decreased 
MDA concentration in the ipsilateral hippocampus 
3 hours after AG+AlCl3 application compared to 
AlCl3-treated group, suggest an intensive depletion 
of this tripeptide in antioxidative defense and the 
elevating of its oxidative form, generated in the 
reactions of oxidative stress. The obtained results 
confirm the NOS inhibitor antioxidative effects ba-
sed on oxidative stress reduction, as well. 
We have shown that 30 days after AG appli-
cation the iNOS inhibitor produced a decrease in 
GSH content, compared to the control and AlCl3-
treated group (Table 3), showing inadequate anti-
oxidative cell defense.  
Mitochondria are essential to the cell for maintai-
ning the normal voltage gradient across the cell mem-
brane as well as a number of processes that control 
intracellular Ca2+. Complex IV, COX, is the last 
component of the mitochondrial electron-transport 
chain. It catalyzes the four-electron reduction of mole-
cular oxygen to water, which is accompanied by pro-
ton translocation into the intramembrane space of 
mitochondria. Nitric oxide or ONOO- could poten-
tially be responsible for the mitochondrial damage 
occurring in the ischemic brain and at inflammatory 
sites. It has been known that NO binds to COX and it 
may act as an inhibitor of this enzyme at physiological 
concentrations. This reaction is reversible and com-
petitive with oxygen. In contrast, ONOO- has little or 
no effect on COX but inhibits respiratory complex I-
III in an apparently irreversible manner (Toiber and 
Soreq, 2005). 
Our previous studies show that COX activity 
decreased bilaterally 7 and 12 days after AlCl3 
application to the hippocampus, forebrain cortex 
and basal forebrain (Jovanović et al., 2000, 2006). 
Under the conditions of this experiment, the 
decrease in COX activity after 3 h and 30 days 
bilaterally in the hippocampus of the AlCl3-treated 
animals compared to the controls (Table 4), indi-
cates a deficiency in reducing equivalents with a 
consequent diminishing of the proton gradient, i.e. 
reentering of protons to the mitochondria, followed 
by insufficient ATP synthesis. Aluminum impedes 
glycolysis, followed by a decreased production of 
reducing equivalents, which are necessary for the 
regeneration/synthesis of the GSH form, as well as 
for the maintenance of the proton gradient and 
functionality of the mitochondrial electron-trans-
port chain. 
The decreased activity of COX in AG+AlCl3-
treated rats, compared to the control (Table 4), 
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suggests the existence of oxidative stress. This pro-
cess appears to be due to the effects of AlCl3. One of 
its effects could be mediated through a decrease in 
synthesis of NADH. However, we have shown that 
the application of AG+AlCl3 produced an increase 
in COX activity, compared to the AlCl3-treated 
animals (Table 4). Literature results (Madrigal et al., 
2001), implicate that administration of the pre-
ferred iNOS inhibitor protects against the inhi-
bition of the activity of complexes of the mitochon-
drial respiratory chain as well as preventing NO 
accumulation, lipid peroxidation and GSH deple-
tion induced by stress.  
We used immunohistochemistry to examine the 
expression of iNOS in the CNS of old adult rats (3 
month-old). Inducible NOS-positive cells occurred 
in perivascular cells 3 h after saline solution 
administration (Fig. 1A). However, the maximal ex-
pression of iNOS occurred 3 h after AlCl3 appli-
cation in the hippocampus (Fig. 1B). This could be 
the result of brain-blood barrier disruption and 
induced inflammation in the rat brain (Heneka et 
al., 2000). Our data suggests that no labeling of cells 
for iNOS was seen 3 h after AG+AlCl3-injection 
(Fig. 1C), or AG-injection in rat brain (Fig. 1D). 
Aminoguanidine, as a selective inhibitor of the 
inducible form of NOS, inhibits enzyme activity 
applied with neurotoxin or saline solution, res-
pectively. 
CONCLUSION 
The decreased COX activity as well as increased 
nitrite levels, MDA concentration and GSH content 
after 3 h and 30 days of AlCl3 treatment bilaterally 
in the hippocampus indicate the propagation of 
oxidative stress. Intrahippocampal administration 
of AlCl3 could induce an aggregation of the 
cytoskeletal elements, forming very stable connec-
tions between phosphate groups of the hyperphos-
phorilated tau elements – low molecular weight 
microtubule associated proteins. These changes 
could cause retrograde trans-neuronal damage of 
the cholinergic neurons in the basal forebrain, with 
consequent damage of the cholinergic inputs in the 
hippocampus. In this case, NOS inhibitors such as 
AG could have a potentially neuroprotective effect. 
REFERENCES 
M.E. Anderson (1986): Tissue glutathione: Handbook of 
Methods for Oxygen Radical Research, 317-323. Boca 
Raton, CRC Press Inc.  
Bojarski, L., Herms, J., and J. Kuznicki (2008): Calcium dysregula-
tion in Alzheimer's disease. Neurochem. Int. 52, 621-633.  
Christen, Y., (2000): Oxidative stress and Alzheimer΄s disease. 
Am. J. Clin. Nutr. 71(2), 621S-629S. 
Combs, C.K., Karlo, J.C., Kao, S.C., and G.E. Landreth (2001): 
βAmyloid stimulation of microglia and monocytes 
results in TNFα-dependent expression of inducible nit-
ric oxide synthase and neuronal apoptosis. J. Neurosci. 
21(4), 1179-1188. 
Dave, K.R., Syal, A.R., and S.S. Katyare (2002): Effect of long-
term aluminium feeding on kinetics attributes of tissue 
cholinesterases. Brain Res. Bull. 58, 225-233. 
Ferreira, P.C., Piai Kde, A., Takayanagui, A.M., and S.I. Segura-
Muñoz (2008): Aluminum as a risk factor for Alzheimer's 
disease. Rev. Latino-am. Enfermagem. 16(1), 151-157. 
Fiskum, G., Rosenthal, R.E., Vereczki, V., Martin, E., Hoffman, 
G.E., Chinopoulos, C., and A. Kowaltowski (2004): 
Protection against ischemic brain injury by inhibition of 
mitochondrial oxidative stress. J. Bioenerg. Biomembr. 
36(4), 347-352. 
Fratelli, M., Goodwin, L.O., Orom, U.A., Lombardi, S., Tonelli, 
R., Mengozzi, M., and P. Ghezzi (2005):  Gene ex-
pression profiling reveals a signaling role of glutathione 
in redox regulation. Proc. Natl. Acad. Sci. U.S.A. 
102(39), 13998-14003. 
Ghribi, O., DeWitt, D.A., Forbes, M.S., Herman, M.M., and J. 
Savory (2001): Co-involvement of mitochondria and 
endoplasmic reticulum in regulation of apoptosis: 
changes in cytochrome c, Bcl-2 and Bax in the hippo-
campus of aluminium-treated rabbits. Brain Res. 903(1-
2), 66-73. 
Gorlach, C., Hortobagyi, T., Benyo, Z., and M. Wahl (2000): 
Aminoguanidine reduces brain lesion volume after cold 
injury in the rat. Pflugers Arch. 440(2), 309-314. 
Gurd, J.W., Jones, L.R., Mahler, H.R., and W.J. Moore (1974): 
Isolation and partial characterization of rat brain 
synaptic plasma membranes. J. Neurochem. 22, 281-290. 
Haddad, J.J., and H.L. Harb (2005): L-gamma-Glutamyl-L-
cysteinyl-glycine (glutathione; GSH) and GSH-related 
enzymes in the regulation of pro- and anti-
inflammatory cytokines: a signaling transcriptional sce-
990 I. D. STEVANOVIĆ ET AL. 
nario for redox(y) immunologic sensor(s)? Mol. Immu-
nol. 42(9), 987-1014. 
Heneka, M.T., Dumitrescu, L., Löschmann, P.A., Wüllner, U., 
and T. Klockgether (2000): Temporal, regional, and cell-
specific changes of iNOS expression after intrastriatal 
microinjection of interferon gamma and bacterial 
lipopolysaccharide. J. Chem. Neuroanat. 18, 167-179. 
Heneka, M.T., and D.L. Feinstein (2001): Expression and 
function of inducible nitric oxide synthase in neurons. J. 
Neuroimmunol. 114(1-2), 8-18. 
Hess, H.H., and A. Pope (1960): Intralaminar distribution of 
cytochrome oxidase activity in human frontal isocortex. 
J. Neurochem. 5, 207-217. 
Jovanović, M., Ninković, M., Maličević, Ž., Mihajlović, R., Mićić, 
D., Vasiljević, I., and V. Selaković (2000): Cytochrome C 
oxidase activity and total glutathione content in 
experimental model of intracerebral aluminum over-
load. Vojnosanit. Pregl. 57(3), 265-270. 
Jovanović, M., Jelenković, A., Vasiljević, I., Bokonjić, D., Čolić, 
M., Marinković, S., and D. Stanimirović (2006): Intra-
cerebral aluminum intoxication: An involvement of 
oxidative damage, In: Neurobiological Studies - From 
Genes to Behaviour, (Eds. S. Ruždijić, and Lj. Rakić),  
259-271. Research Signpost, Kerala, India.             
Juranek, I., and S. Bezek (2005): Controversy of free radical 
hypothesis: reactive oxygen species-cause or consequen-
ce of tissue injury? Gen. Physiol. Bioph. 24(3), 263-278. 
Kawahara, M., Kato, M., and Y. Kuroda (2001): Effects of 
aluminum on the neurotoxicity of primary cultured 
neurons and on the aggregation of beta-amyloid 
protein. Brain Res. Bull. 55, 211-217. 
König, J.F.R., and R.A. Klippel (1963): A stereotaxic atlas of the 
forebrain and lower parts of the brain stem: The rat 
brain, 53. The Williams and Wilkins company, 
Baltimore, USA. 
Law, A., Gauthier, S., and R. Quirion (2001): Say NO to 
Alzheimer΄s disease: the putative links between nitric 
oxide and dementia of the Alzheimer΄s type. Brain Res. 
Rew. 35(1), 73-96. 
Li, W., Ma, K.K., Sun, W., and H.K. Paudel (1998): Phosphorylation 
sensitizes microtubule-associated protein tau to Al(3+)-
induced aggregation. Neurochem. Res. 23(12), 1467-1476. 
Lowry, O.H., Rosenbrough, N.J., Farr, A.L., and R.J. Randall 
(1951): Protein measurement with folin phenol reagent. 
J. Biol. Chem. 193, 265-275. 
Madrigal, J.L., Olivenza, R., Moro, M.A., Lizasoain, I., Lorenzo, 
P., Rodrigo, J., and J.C. Leza (2001): Glutathione 
depletion, lipid peroxidation and mitochondrial dys-
function are induced by chronic stress in rat brain. 
Neuropsychopharmacol. 24(4), 420-429. 
Mousavi, M., and E. Hellström-Lindahl (2009): Nicotinic 
receptor agonists and antagonists increase sAPPalpha 
secretion and decrease Abeta levels in vitro. Neurochem. 
Int. 54, 237-244.  
Mundy, W.R., Fraudenrich, T.M., and P.R. Kodavanti (1997): 
Aluminum potentiates glutamate-induced calcium 
accumulation and iron-induced oxygen free radical 
formation in primary neuronal cultures. Mol. Chem. 
Neuropathol. 32(1-3), 41-57. 
Navarro-Gonzalvez, J.A., Garcia-Benayas, C., and J. Arenas 
(1998): Semiautomated measurement of nitrate in biolo-
gical fluids. Clin. Chem. 44, 679-681. 
Olivenza, R., Moro, M.A., Lizasoain, I., Lorenzo, P., Fernandez, 
A.P., Rodrigo, J., Bosca, L., and J.C. Leza (2000): Chronic 
stress induces the expression of inducible nitric oxide 
synthase in rat brain cortex. J. Neurochem. 74(2), 785-791. 
Pannu, R., and I. Singh (2007): Pharmacological strategies for 
the regulation of inducible nitric oxide synthase: 
Neurodegenerative versus neuroprotective mechanisms. 
Neurochem. Internat. 49(2), 170-182. 
Schubert, P., Ogata, T., Merchini, C., and S. Ferroni (2001): 
Glia-related pathomechanisms in Alzheimer΄s disease: a 
therapeutic target? Mech. Ageing Dev. 123(1), 47-57. 
Sheldon, A.L., and M.B. Robinson (2007): The role of glutamate 
transporters in neurodegenerative diseases and potential 
opportunities for intervention. Neurochem. Internat. 
51(6-7), 333-355. 
Stanczyk, M., Gromadzinska, J., and W. Wasowicz (2005): Roles 
of reactive oxygen species and selected antioxidants in 
regulation of cellular metabolism. Int. J. Occup. Med. 
Environ. Health. 18(1), 15-26. 
Stepanichev, M.Y., Onufriev, V., Yakovlev, A.A., Khrenov, A.I., 
Peregud, D.I., Vorontsova, O.N., Lazareva, N.A., and 
N.V. Gulyaeva (2008): Amyloid-beta (25-35) increases 
activity of neuronal NO-synthase in rat brain. Neuro-
chem. Int. 52, 1114-1124. 
Stevanović, I., Jovanović, M., Jelenković, A., Čolić, M., Stojano-
vić, I., and M. Ninković (2008): The effect of 7-nitro-
indazole on aluminum toxicity in the rat brain. Bulg. J. 
Vet. Med. 11(1), 37-47. 
Stevanović, I., Jovanović, M., Jelenković, A., Čolić, M., Stojano-
vić, I., and M. Ninković (2009): Effects of L-NAME, a 
non-specific nitric oxide synthase inhibitor, on AlCl3-
induced toxicity in the rat forebrain cortex. J. Vet. Sci. 
10(1), 15-22. 
Stevanović, I.D., Jovanović, M.D., Čolić, M., Jelenković, A., 
Bokonjić, D., and M. Ninković (2010): Nitric oxide syn-
thase inhibitors protect cholinergic neurons against 
AlCl3 excitotoxicity in the rat brain. Brain Res. Bull. 81, 
641-646. 
 THE EFFECT OF AMINOGUANIDINE ON AlCl3 TOXICITY IN THE RAT BRAIN 991 
Tohgi, H., Abe, T., Yamazaki, K., Murata, T., Isobe, C., and E. 
Ishizaki (1998): The cerebrospinal fluid oxidized NO 
metabolites, nitrite and nitrate in AD and vascular 
dementia of Binswanger type and multiple small infarct 
type. J. Neural. Transm. 105(10-12), 1283-1291. 
Toiber, D., and H. Soreq (2005): Cellular stress reactions as 
putative cholinergic links in Alzheimer`s disease. 
Neurochem. Res. 30(3/7), 909-919. 
Van Gelder, W., Huijskes-Heins, M.I., Van Dijk, J.P., Cleton-
Soeteman, M.I., and H.G. Van Eijk (1995): Quantifi-
cation of different transferrin receptor pools in primary 
cultures of porcine blood-brain barrier endothelial cells. 
J. Neurochem. 64(6), 2708-2715. 
Villacara, A., Kumami, K., Yamamoto, T., Mršulja, B.B., and 
M. Spatz (1989): Ischemic modification of cerebro-
cortical membranes: 5-hydroxytriptamine receptors, 
fluidity, and inducible in vitro lipid peroxidation. J. 
Neurochem. 53(2), 595-601. 
Yang, E.Y., Guo-Ross, S.X., and S.C. Bondy (1999): The 
stabilization of ferrous iron by a toxic beta-amyloid 
fragment and by an aluminum salt. Brain Res. 839(2), 
221-226. 
Zatta, P., Ibn-Lkayat-Idrissi, M., Zambenedetti, P., Kilyen, M., 
and T. Ki ss (2002): In vivo and in vitro effects of 
aluminum on the activity of mouse brain acetylcho-
linestrase. Brain Res. Bull. 59, 41-45. 
EFEKAT AMINOGVANIDINA, INHIBITORA AZOT OKSID SINTAZE, NA TOKSIČNOST ALCL3 U 
HIPOKAMPUSU PACOVA 
I. D. STEVANOVIĆ1, M. D. JOVANOVIĆ1, M. ČOLIĆ1, A. JELENKOVIĆ2, R. MIHAJLOVIĆ3, I. 
STOJANOVIĆ4, i M. NINKOVIĆ1 
1Vojnomedicinska akademija, Institut za medicinska istraživanja, 11000 Beograd, Srbija 
2Institut za biološka istraživanja ˝Siniša Stanković˝, 11000 Beograd, Srbija 
3Institut za rehabilitaciju, 11000 Beograd, Srbija 
4Medicinski fakultet Univerziteta u Nišu, Institut za biohemiju, 18000 Niš, Srbija 
U eksperimentu je određivana efikasnost inhibitora 
inducibilne forme azot oksid sintaze – aminogvanidina, 
u modulaciji toksičnosti aluminijum hlorida na nivo 
nitrita, koncentraciju malondialdehida, sadržaj reduko-
vanog glutationa, kao i aktivnost citohrom c oksidaze 
kod Wistar pacova. Životinje su dekapitovane 3 časa i 
30 dana nakon odgovarajućeg tretmana i izolovan je 
hipokampus. Rezultati dobijeni na biohemijskom nivou 
pokazuju da aluminijum deluje kao pro-oksidant, dok 
aminogvanidin pokazuje antioksidativno dejstvo kod 
životinja tretiranih aluminijum hloridom. Pored toga, 
korišćene su i imunohistohemijske tehnike za iden-
tifikaciju iNOS ekspresije, 3 časa nakon primene odgo-
varajućeg tretmana. Naši rezultati pokazuju da amino-
gvanidin može sprečiti toksičnost indukovanu alumini-
jum hloridom. 
